[NH2:1][C:2]1[N:3]=[C:4]2[CH:9]=[CH:8][C:7]([O:10][C:11]3[CH:12]=[C:13]([NH:17][C:18]([C:20]4[C:25]([CH3:26])=[CH:24][CH:23]=[CH:22][N:21]=4)=[O:19])[CH:14]=[CH:15][CH:16]=3)=[CH:6][N:5]2[CH:27]=1.[N:28]1([CH2:34][C:35](O)=[O:36])[CH2:33][CH2:32][O:31][CH2:30][CH2:29]1.Cl.CN(C)CCCN=C=NCC.N1(O)C2C=CC=CC=2N=N1.C(N(CC)C(C)C)(C)C>C(=O)([O-])O.[Na+].CN(C)C(=O)C>[CH3:26][C:25]1[C:20]([C:18]([NH:17][C:13]2[CH:14]=[CH:15][CH:16]=[C:11]([O:10][C:7]3[CH:8]=[CH:9][C:4]4[N:5]([CH:27]=[C:2]([NH:1][C:35](=[O:36])[CH2:34][N:28]5[CH2:33][CH2:32][O:31][CH2:30][CH2:29]5)[N:3]=4)[CH:6]=3)[CH:12]=2)=[O:19])=[N:21][CH:22]=[CH:23][CH:24]=1A mixture of N-{3-[(2-aminoimidazo[1,2-a]pyridin-6-yl)oxy]phenyl}-3-methylpyridine-2-carboxamide (129 mg, 0.359 mmol), morpholin-4-ylacetic acid (56.8 mg, 0.391 mmol), N-[3-(dimethylamino)propyl]-N′-ethylcarbodiimide hydrochloride (97.8 mg, 0.510 mmol), 1H-benzotriazol-1-ol (50.7 mg, 0.375 mmol), N,N-diisopropylethylamine (123 μL, 0.719 mmol) and N,N-dimethylacetamide (5 mL) was stirred at room temperature for 21 hr. The reaction mixture was diluted with aqueous sodium hydrogen carbonate solution and extracted with ethyl acetate. The organic layer was washed with aqueous sodium hydrogen carbonate solution and saturated brine, dried over anhydrous magnesium sulfate and filtrated. The filtrate was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (NH silica gel, 0%→75% ethyl acetate-hexane) to give the title compound (82.8 mg, 47%) as a pale-yellow solid.